Impingement syndrome often arises due to mechanical compression or crowding of soft tissues. It is commonly treated through physiotherapy or non-steroidal anti-inflammatory drugs as initial measures. However, surgical decompression or repair may be pursued in refractory cases. Factors such as faster recovery, less pain and scarring have boosted the adoption of minimally invasive surgical procedures for impingement syndrome management. Arthroscopy, which facilitates direct visualization and treatment of involved structures using small incisions, has emerged as a preferred minimal access option. The global Impingement Syndrome Market is estimated to be valued at US$ 2,173.5 Mn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The preference for minimally invasive treatments for impingement syndrome has propelled the demand for enabling technologies. Arthroscopic visualization systems and equipment have witnessed widespread uptake. Sophisticated arthroscopes with advanced optics offer high definitionimaging that enhances visualization during such procedures. Adoption of robot-assisted surgery is also on the rise. Systems that provide three-dimensional views, tremor filtration and precision instrument control have made inroads. Innovation in arthroscopic surgical instruments and implants used for reconstruction further advances treatment efficacy and safety. Emergence of biosurgical adjuncts has likewise expanded the product landscape to improve clinical outcomes. Such trends are slated to bolster the impingement syndrome market gains through the forecast period.
SWOT Analysis
Strength: The impingement syndrome market is expected to grow at a steady rate due to the rising geriatric population and increasing number of sports injuries.
Weakness: High costs associated with diagnosis and surgical procedures for impingement syndrome can hamper the market growth.
Opportunity: Launch of advanced techniques such as arthroscopic subacromial decompression surgery provide new opportunities for market growth.
Threats: Availability of alternative treatment methods and lack of awareness about impingement syndrome in some regions pose challenges.
Key Takeaways
The global impingement syndrome market is expected to witness high growth over the forecast period of 2023-2030.
North America is currently the fastest growing regional market for impingement syndrome. Factors such as rising healthcare expenditure, growing obese population, and increasing awareness among individuals are driving the North American market.
Key players operating in the impingement syndrome market are Thermo Fisher Scientific Inc., GE Healthcare, Merck KGaA, Bio-Rad Laboratories, Inc., Lonza, Abcam plc, PerkinElmer Inc., Bio-Techne, BioVision Inc., Cell Signaling Technology, Inc., and Geno Technology Inc. These players are focusing on new product launches and geographic expansions to increase their market share. For instance, in 2021, Abcam plc launched various new antibodies for research on impingement syndrome.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
